Ignite Creation Date:
2025-12-25 @ 12:29 AM
Ignite Modification Date:
2025-12-31 @ 12:03 PM
Study NCT ID:
NCT00787267
Status:
TERMINATED
Last Update Posted:
2016-06-30
First Post:
2008-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-06
First Submit QC Date:
None
Study First Post Date:
2008-11-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-19
Results First Submit QC Date:
None
Results First Post Date:
2015-01-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-31
Last Update Post Date:
2016-06-30
Last Update Post Date Type:
ESTIMATED